These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22628002)

  • 1. Comparative effectiveness research in cancer screening programmes.
    Bretthauer M; Hoff G
    BMJ; 2012 May; 344():e2864. PubMed ID: 22628002
    [No Abstract]   [Full Text] [Related]  

  • 2. New approach presented in Norway for large-scale cancer screening programs.
    Lake F
    J Comp Eff Res; 2012 Jul; 1(4):303-4. PubMed ID: 24237461
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness research takes a stand on cancer screening: even if the data are there, effective communication of results is key.
    Nelson B
    Cancer Cytopathol; 2012 Feb; 120(1):1-2. PubMed ID: 22331698
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of timely information in national cancer screening programmes.
    Droljc A; Grbec T; Orel A
    Stud Health Technol Inform; 2009; 150():81-5. PubMed ID: 19745271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening in an expanding panorama of screening programmes.
    Hoff G
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):521-7. PubMed ID: 20833354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness research and cancer screening in the United States and Europe.
    Howard DH
    Med Decis Making; 2009; 29(6):NP12-3. PubMed ID: 19959803
    [No Abstract]   [Full Text] [Related]  

  • 7. Age for starting cervical cancer screening in England will not be lowered.
    Wise J
    BMJ; 2009 Jun; 338():b2583. PubMed ID: 19561053
    [No Abstract]   [Full Text] [Related]  

  • 8. The best screening test for colorectal cancer is the one that gets done well.
    Allison JE
    Gastrointest Endosc; 2010 Feb; 71(2):342-5. PubMed ID: 20152313
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in socioeconomic disparities in organized and opportunistic gastric cancer screening in Korea (2005-2009).
    Lee HY; Park EC; Jun JK; Hahm MI; Jung KW; Kim Y; Han MA; Choi KS
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1919-26. PubMed ID: 20647409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention center.
    Boursi B; Guzner-Gur H; Mashich Y; Miler U; Gur E; Inbar R; Blachar A; Sperber F; Kleiman S; Yafo A; Elran H; Sella T; Naumov I; Kazanov D; Kraus S; Galazan L; Reshef N; Sion-Tadmor T; Rozen M; Liberman E; Moshkowitz M; Arber N
    Isr Med Assoc J; 2010 Jan; 12(1):21-5. PubMed ID: 20450124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer is the most common cancer.
    East Mediterr Health J; 2010 Oct; 16(10):1021. PubMed ID: 21222415
    [No Abstract]   [Full Text] [Related]  

  • 12. Experiences of recall after mammography screening--a qualitative study.
    Solbjør M; Forsmo S; Skolbekken JA; Sætnan AR
    Health Care Women Int; 2011 Nov; 32(11):1009-27. PubMed ID: 21978146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological mass screening in Ostfold County, Norway.
    Magnus K; Langmark F
    IARC Sci Publ; 1986; (76):87-90. PubMed ID: 3570418
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast and cervical cancer screening programme implementation in 16 countries.
    Dowling EC; Klabunde C; Patnick J; Ballard-Barbash R;
    J Med Screen; 2010; 17(3):139-46. PubMed ID: 20956724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Responsible cancer screening].
    Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ
    Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening in women: An integrative literature review.
    Ravert PK; Huffaker C
    J Am Acad Nurse Pract; 2010 Dec; 22(12):668-73. PubMed ID: 21129075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mass screening for early-stage cancer of the uterine cervix].
    Gunbjørud AB; Stenling CA
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3053-4. PubMed ID: 1948913
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards an optimal interval for prostate cancer screening.
    van Leeuwen PJ; Roobol MJ; Kranse R; Zappa M; Carlsson S; Bul M; Zhu X; Bangma CH; Schröder FH; Hugosson J
    Eur Urol; 2012 Jan; 61(1):171-6. PubMed ID: 21840117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer screening: evidence and practice in Europe 2008.
    Hakama M; Coleman MP; Alexe DM; Auvinen A
    Eur J Cancer; 2008 Jul; 44(10):1404-13. PubMed ID: 18343653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.